|
EP3509699A1
|
|
Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
|
|
WO2018047176A1
|
|
Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy
|
|
KR20180054821A
|
|
Triterpenoid-containing composition
|
|
KR20180053406A
|
|
Triterpenoid-containing composition
|
|
AU2015203595A1
|
|
Therapeutic uses of mastic gum fractions
|
|
IL237621D0
|
|
Use of isolated fractions of mastic gum for treating optic neuropathy
|
|
WO2013186766A1
|
|
Extracts and therapeutic uses thereof
|
|
ZA201203477B
|
|
Therapeutic uses of oligomeric and polymeric monoterpenes
|
|
IL219184D0
|
|
Therapeutic uses of oligomeric and polymeric monoterpenes
|
|
CN103167871A
|
|
Compositions comprising acidic extracts of mastic gum
|
|
AU2010310946A1
|
|
Therapeutic uses of oligomeric and polymeric monoterpenes
|
|
CA2754565A1
|
|
Compositions of polymeric myrcene
|
|
EP2403505A2
|
|
Therapeutic uses of mastic gum fractions
|
